When?
Present in maternal blood as early as 5 weeks, and reaches optimal level for analysis at 10 weeks LO 1999
Routine screening: 18+21 >99% effective 0.1% FPR
Krypos et al (2012)
Limitations
Vanishing twin, placental mosaicism, detect maternal problem, low cffDNS conc (BMI)
Not diagnostic, patient declined amnio in favour of NIPT, FP
Smith et al (2013)